We are testing a new cell therapy to see if it helps patients with acute respiratory distress syndrome caused by viruses like COVID-19 and influenza. The study will evaluate its safety and effectiveness in reducing severe immune responses.
Health conditions and diseases that the clinical trial is designed to study and treat.
Acute Respiratory Distress Syndrome (ARDS) is a life-threatening condition characterized by severe inflammation in the lungs, often caused by infections such as SARS-CoV-2, influenza A, B, and respiratory syncytial virus (RSV). It leads to difficulty breathing and low oxygen levels in the blood.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.